Gara Jalqabaatti › Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa
Qorannoo klinikaalii Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa Ameerikaa Keessatti hirmaatuu
Qorannoo 19 Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 7
- Houston, TXQorannoo 6
- Miami, FLQorannoo 6
- New Haven, CTQorannoo 5
- St. Louis, MOQorannoo 5
- Kansas City, KSQorannoo 5
- Indio, CAQorannoo 5
- Philadelphia, PAQorannoo 5
- San Francisco, CAQorannoo 4
- Washington, DCQorannoo 4
- Birmingham, ALQorannoo 4
- Orlando, FLQorannoo 4
- Tampa, FLQorannoo 4
- Cleveland, OHQorannoo 4
- Milwaukee, WIQorannoo 4
- Seattle, WAQorannoo 3
- Portland, ORQorannoo 3
- Cincinnati, OHQorannoo 3
- Scottsdale, AZQorannoo 3
- Austin, TXQorannoo 3
- Centennial, COQorannoo 3
- Boston, MAQorannoo 3
Naannoon
- AlabamaQorannoo 4
- ArizonaQorannoo 4
- CaliforniaQorannoo 11
- ColoradoQorannoo 5
- ConnecticutQorannoo 6
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 11
- IllinoisQorannoo 4
- KansasQorannoo 5
- LouisianaQorannoo 3
- MarylandQorannoo 3
- MassachusettsQorannoo 4
- MichiganQorannoo 5
- MissouriQorannoo 5
- New YorkQorannoo 8
- North CarolinaQorannoo 6
- OhioQorannoo 7
- OregonQorannoo 3
- PennsylvaniaQorannoo 6
- TennesseeQorannoo 3
- TexasQorannoo 10
- WashingtonQorannoo 3
- WisconsinQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05327114A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06752356A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07304154Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06968975Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT07264426A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT06798012Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT07478172A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Dubartoota · Haaromfame 17-Gur-2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06747351IVIG vs SCIG in CIDP
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 99 · Saalaa hunda · Haaromfame 20-Cam-2025 · NCT05004493Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.